Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950168-99-000652
Filing Date
1999-03-04
Accepted
1999-03-04 00:00:00
Documents
15
Period of Report
1998-12-31

Document Format Files

Seq Description Document Type Size
1 PHARMACEUTICAL PRODUCT DEVELOPMENT, INC. 10-K 10-K 279990
2 EXHIBIT 10.118 EX-10 115154
3 EXHIBIT 10.119 EX-10 11769
4 EXHIBIT 10.120 EX-10 11359
5 EXHIBIT 10.121 EX-10 85942
6 EXHIBIT 10.122 EX-10 6043
7 EXHIBIT 10.123 EX-10 10262
8 EXHIBIT 10.124 EX-10 20847
9 EXHIBIT 10.125 EX-10 45825
10 EXHIBIT 10.126 EX-10 44656
11 EXHIBIT 10.127 EX-10 4599
12 EXHIBIT 10.128 EX-10 250265
13 EXHIBIT 21 EX-21 5752
14 EXHIBIT 23.1 EX-23 626
15 FDS -- PHARMACEUTICAL PRODUCT DEVELOPMENT, INC. EX-27 2311
  Complete submission text file 0000950168-99-000652.txt   898108
Mailing Address
Business Address 3151 17TH ST EXTENSION WILMINGTON NC 28401 9102510081
PHARMACEUTICAL PRODUCT DEVELOPMENT INC (Filer) CIK: 0001003124 (see all company filings)

EIN.: 561640186 | State of Incorp.: NC | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-27570 | Film No.: 99557124
SIC: 8731 Services-Commercial Physical & Biological Research